Elan Verelan Consent Decree With FDA Follows Two GMP Warning Letters
Executive Summary
Elan's current good manufacturing practices consent decree with FDA follows two warning letters in the last six years.
You may also be interested in...
Watson/FDA Consent Decree Will Not Involve Product Recalls, Firm Says
Watson does not expect to recall any products manufactured at its Corona, Calif. facility as a result of a proposed consent decree with FDA, CEO Allen Chao, PhD, told analysts in a March 28 conference call
Watson/FDA Consent Decree Will Not Involve Product Recalls, Firm Says
Watson does not expect to recall any products manufactured at its Corona, Calif. facility as a result of a proposed consent decree with FDA, CEO Allen Chao, PhD, told analysts in a March 28 conference call
Schering Compliance Team Will Report To CEO Following COO Resignation
Schering-Plough's compliance team for resolving FDA's Good Manufacturing Practices concerns with the company will report directly to CEO Richard Kogan following the resignation of President & Chief Operating Officer Raul Cesan.